Endoscopic ultrasound (EUS)-through-the-needle biopsy (EUS-TTNB) using Moray microforceps in PCLs ; A Prospective study to evaluate safety and efficacy

Dr Praveer rai0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Age over 18 years old
•2. FNAofthe cystic fluid indicated during an endoscopic ultrasound examination
•3. Abdominal CT and pancreatic MRI less than 3 months old, available
•4. Pancreatic cyst unilocular or with a macrolocule in case of multilocular cyst, of size >= to 20 mmofmajor axis with a clean wall

•1. Contraindication to performing an upper endoscopic ultrasound
•2. Patient with known chronic calcifying pancreatitis, or suspected on the iconography available during the screening visit
•3. Patient taking an antiplatelet, or anticoagulant therapy including anti-vitamin K, direct oral anticoagulant, or heparin. 4. Hemorrhagic disease, hemostasis and coagulation disorder (TP < 60%, TCA > 40 sec. and platelets < 60000/mm3), malignant hematopathy, chronic cirrhotic liver disease with Child Pugh B or C, acute or severe chronic renal failure (creatinine clearance < to 30 ml/min)
•5. Mental disability of the subject making participation in the trial impossible
•6. Patient not affiliated to a social security system
•7. Inability to understand or sign informed consent
•8. Serious adverse events
•9. Early termination of participation, withdrawal of voluntary informed consent of the patient
•10. Violation of protocol

发起方

Dr Praveer rai